Lung Regeneration Therapy for Chronic Obstructive Pulmonary Disease.
- Author:
Dong Kyu OH
1
;
You Sun KIM
;
Yeon Mok OH
Author Information
- Publication Type:Review
- Keywords: Pulmonary Disease, Chronic Obstructive; Cell- and Tissue-Based Therapy; Drug Therapy; Emphysema; Lung; Regeneration; Regenerative Medicine; Retinoids; Stem Cells
- MeSH: Cell- and Tissue-Based Therapy; Drug Therapy; Emphysema; Lung*; Models, Animal; Mortality; Pneumonectomy; Pulmonary Emphysema; Pulmonary Disease, Chronic Obstructive*; Regenerative Medicine; Retinoids; Stem Cells
- From:Tuberculosis and Respiratory Diseases 2017;80(1):1-10
- CountryRepublic of Korea
- Language:English
- Abstract: Chronic obstructive pulmonary disease (COPD) is a critical condition with high morbidity and mortality. Although several medications are available, there are no definite treatments. However, recent advances in the understanding of stem and progenitor cells in the lung, and molecular changes during re-alveolization after pneumonectomy, have made it possible to envisage the regeneration of damaged lungs. With this background, numerous studies of stem cells and various stimulatory molecules have been undertaken, to try and regenerate destroyed lungs in animal models of COPD. Both the cell and drug therapies show promising results. However, in contrast to the successes in laboratories, no clinical trials have exhibited satisfactory efficacy, although they were generally safe and tolerable. In this article, we review the previous experimental and clinical trials, and summarize the recent advances in lung regeneration therapy for COPD. Furthermore, we discuss the current limitations and future perspectives of this emerging field.
